Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players Nov 18, 2025 Life Science
With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity Nov 17, 2025 Life Science
Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value Nov 11, 2025 Life Science
GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game Nov 10, 2025 Life Science
Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
Defensive Plays for a Bear Market: 3 Healthcare Stocks with Robust Dividends Nov 3, 2025 Life Science
Three Canadian Growth Stocks Garner Unanimous “Strong Buy” Ratings from Analysts Nov 3, 2025 Life Science
Who Will Be the Next Winner in the Weight-Loss Drug Market? BioAge Labs Attracts Attention Oct 30, 2025 Life Science
With Yields Exceeding 5%, These Two High-Dividend Stocks Are Worth Watching Oct 29, 2025 Consumer Goods, Life Science
Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential Oct 28, 2025 Life Science
